Repros Therapeutics, Inc. (RPRX) Posts Q1 Loss of 37c/Share
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.41 -0.88%
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q1 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Arrive AI and DXC Technology partner to bring delivery tech to factories
- Amneal gets FDA approval for lanreotide injection, launches immediately
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
